Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (588)	4/8/2006 11:59:33 AM
From: nigel bates	of 590

Completion date of 1st April was entirely apt, IMO... "We continue to believe Amgen retains a high level of confidence of the use of panitumumab (Pmab) in first-line metastatic colorectal cancer to support its estimate of worldwide peak sales of $2 billion (including all indications)..." siliconinvestor.com AMGN paid 1x potential peak sales for PMab & the rest for free ?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next